1,5-Benzodiazepines as CCK-B antagonists. Effect of halogen substitution at the benzo-fused ring on potency and selectivity
- 21 December 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (24) , 3011-3016
- https://doi.org/10.1016/0960-894x(95)00528-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Modulatory Role for CCK-B Antagonists in Parkinsonʼs DiseaseClinical Neuropharmacology, 1990
- Influences of cholecystokinin and analogues on memory processesDrug Development Research, 1990
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988
- Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsJournal of Medicinal Chemistry, 1987
- Psychopharmacological Profile of Cholecystokinin Using the Self-Stimulation and the Drug Discrimination ParadigmsaAnnals of the New York Academy of Sciences, 1985
- Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in manLife Sciences, 1985
- Behavioral and neurophysiological evidence for a facilatory interaction between co-existing transmitters: cholecystokinin and dopamineNeurochemistry International, 1984
- THE PHYSIOLOGY OF CHOLECYSTOKININ IN BRAIN AND GUTBritish Medical Bulletin, 1982
- The ascent of cholecystokinin (CCK) — From gut to brainLife Sciences, 1982
- New peptide in the vertebrate CNS reacting with antigastrin antibodiesNature, 1975